Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
The purpose of this pilot study will be to provide i) information on feasibility implementing an exercise intervention trial among patients with cutaneous cancers, including melanoma, squamous cell carcinoma (cuSCC), and Merkel cell carcinoma, scheduled to receive checkpoint blockade immunotherapy, and ii) preliminary data on the impact of a day-of-therapy exercise intervention.
Epistemonikos ID: 03bf8be55ab78f1922e2e89fba0922c091a6055f
First added on: Oct 02, 2023